Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma

BACKGROUND: This phase 2 multi-institutional study was designed to determine whether gemcitabine (GEM) with fractionated stereotactic body radiotherapy (SBRT) results in acceptable late grade 2 to 4 gastrointestinal toxicity when compared with a prior trial of GEM with single-fraction SBRT in patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Herman, Joseph M, Chang, Daniel T, Goodman, Karyn A, Dholakia, Avani S, Raman, Siva P, Hacker-Prietz, Amy, Iacobuzio-Donahue, Christine A, Griffith, Mary E, Pawlik, Timothy M, Pai, Jonathan S, O'Reilly, Eileen, Fisher, George A, Wild, Aaron T, Rosati, Lauren M, Zheng, Lei, Wolfgang, Christopher L, Laheru, Daniel A, Columbo, Laurie A, Sugar, Elizabeth A, Koong, Albert C
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4368473/
https://ncbi.nlm.nih.gov/pubmed/25538019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29161
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados